FIORUCCI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 10.631
EU - Europa 8.823
AS - Asia 1.694
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 6
OC - Oceania 3
Totale 21.200
Nazione #
US - Stati Uniti d'America 10.532
IE - Irlanda 2.041
UA - Ucraina 1.999
SE - Svezia 1.438
IT - Italia 1.108
VN - Vietnam 623
HK - Hong Kong 565
FI - Finlandia 550
DE - Germania 517
RU - Federazione Russa 442
GB - Regno Unito 224
CN - Cina 215
FR - Francia 184
TR - Turchia 117
CH - Svizzera 87
CA - Canada 86
KR - Corea 74
AT - Austria 44
BE - Belgio 39
PL - Polonia 33
NL - Olanda 31
UZ - Uzbekistan 31
LB - Libano 25
SG - Singapore 25
GR - Grecia 23
RO - Romania 20
BR - Brasile 19
CZ - Repubblica Ceca 15
EU - Europa 15
MX - Messico 13
ES - Italia 8
JP - Giappone 5
BG - Bulgaria 4
CO - Colombia 3
PY - Paraguay 3
AL - Albania 2
AU - Australia 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
HR - Croazia 2
IN - India 2
IR - Iran 2
LT - Lituania 2
RS - Serbia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GH - Ghana 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 21.200
Città #
Chandler 2.286
Dublin 2.032
San Mateo 1.227
Jacksonville 837
Dong Ket 622
Hong Kong 565
Medford 547
Princeton 542
Altamura 518
Wilmington 497
Lawrence 381
Andover 345
Ann Arbor 341
Des Moines 313
Perugia 235
Saint Petersburg 165
Ashburn 158
Beijing 139
Izmir 116
Boardman 106
Norwalk 96
Falls Church 95
Ottawa 77
Helsinki 71
Woodbridge 64
San Paolo di Civitate 57
Brussels 39
Shanghai 39
Redwood City 35
New York 33
Redmond 33
Houston 30
Auburn Hills 25
Den Haag 25
Moscow 25
Dearborn 23
Timisoara 18
Singapore 15
Chicago 14
Los Angeles 14
Lausanne 13
Tappahannock 12
Rome 10
Vienna 10
Florence 9
Frankfurt Am Main 9
Lappeenranta 9
Philadelphia 9
San Diego 8
Simi Valley 8
Naples 7
Seattle 7
Brugg 6
Kiev 6
London 6
Nanjing 6
Toronto 6
Amsterdam 5
Cambridge 5
Cuauhtémoc 5
Ludwigshafen 5
São Paulo 5
Tokyo 5
Bologna 4
Dallas 4
Fairfield 4
Fremont 4
Menlo Park 4
Napoli 4
Phoenix 4
Catania 3
Edinburgh 3
Fernando De La Mora 3
Giugliano In Campania 3
Guangzhou 3
Hanover 3
Lugano 3
Madrid 3
Mexico City 3
Milan 3
Prata Di Pordenone 3
Rovato 3
State College 3
Stockholm 3
Terni 3
Zhengzhou 3
Abidjan 2
Arzano 2
Atripalda 2
Bedford 2
Belgrade 2
Caldogno 2
Campinas 2
Castellammare di Stabia 2
Cincinnati 2
Cormeilles-en-Parisis 2
Council Bluffs 2
Crispano 2
Esslingen am Neckar 2
Falkenstein 2
Totale 13.075
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 154
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 131
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 87
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 84
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 82
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 80
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 80
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 80
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 80
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 79
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 79
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 76
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 76
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 76
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 76
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 75
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 75
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 75
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 74
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 74
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 73
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 70
A magic bullet for mucosal protection...and aspirin is the trigger! 70
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 69
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 68
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 68
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 67
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 67
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 66
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 66
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 66
Antiatherosclerotic effect of farnesoid X receptor. 66
Endothelial nitric oxide synthase: the Cinderella of inflammation? 66
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 65
PPARs and other nuclear receptors in inflammation. 65
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 65
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 65
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 65
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 65
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 64
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 64
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 63
LESIONI FOCALI EPATICHE MALIGNE 63
Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by a nitric oxide-dependent pathway 63
Nitric oxide-releasing NSAIDs: a review of their current status. 62
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 62
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 62
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 61
Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells 61
Barriera mucosa esofagea e meccanismi aggressivi. 61
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 60
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 60
Anatomia del fegato 60
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 60
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 59
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 59
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 59
Antinfiammatori non steroidei 59
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 59
NO-aspirin: mechanism of action and gastrointestinal safety 58
NSAID-induced TNF alpha release from macrophages is the key mediator of gastric mucosal injury. 58
A new nitric oxide steroid derivative (NCX 1015) with enhanced anti-inflammatory properties reduces colonic inflammation in mice. 58
Atti VII convegno nazionale GISMAD 58
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 58
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 58
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 58
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. 57
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 57
Hyperglycemia Inhibits the Erythromycin-induced Gallbladder Emptying In Normal Subjects 57
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 57
Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. 56
Indomethacin modulates Mac-1 expression on circulating neutrophils by inducing Ca2+ mobilization and tyrosine kinase activation. 56
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 56
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 56
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 56
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 56
Helicobacter pylori and non-steroidal anti-inflammatory drugs. 55
Nitric oxide inhibits hepatic stellate cell dependent tumor angiogenesis in primary and metastatic liver cancer 55
The Fanesoid-X-Receptor ligand INT-747 regulates organic transporters alpha and beta (Ost alpha and Ost beta) in liver cells and rodent model of cholestasis 55
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. 55
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 55
Gynecomastia During Omeprazole Therapy 54
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy 54
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 54
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 54
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 54
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 54
Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future. 53
Current Advances In Therapeutic Applications of Nuclear Receptors 53
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 53
Effect of Acute An Chronic Administration of Erythromycin On Gastrointestinal Motility In Scleroderma Patients 53
Function of Cd44 Variant Isoforms In Human T-cells 53
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 53
NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice. 53
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 53
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 53
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 53
Title: nitric oxide and lipoxins: role in inflammation and defence. 52
Nitric oxide protects againist HIV gp 120 endothelial injury. 52
Proteinase activated receptor (PAR)-2 agonistic peptide protects from Th-1 mediated liver injury in mice. 52
Totale 6.441
Categoria #
all - tutte 81.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019220 0 0 0 0 0 0 0 0 0 46 161 13
2019/20201.802 48 61 243 12 260 53 297 85 417 159 36 131
2020/20214.489 21 387 208 399 1.279 312 215 29 439 166 316 718
2021/20224.328 96 816 68 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20241.575 206 312 144 50 35 21 464 146 162 35 0 0
Totale 22.020